The Young Investigators Training Course is designed to intensively train selected young investigators in the SWOG system for protocol development, maintenance, and administration in order to develop a cadre of experts to quickly and efficiently develop priority studies. For the purposes of this training, young investigators are defined as oncology fellows in training or assistant …
We are pleased to report that The Hope Foundation has received notification of its continued Accreditation status from the Accreditation Council for Continuing Medical Education (ACCME). Staff members who worked diligently throughout the reaccreditation process are thrilled that Hope’s CME program has demonstrated compliance. We look forward to continuing to improve our educational programming to …
The next SWOG Group Meeting will be held April 30 – May 3, 2014, at the Hyatt Regency in San Francisco. This four-day event will feature a full and varied agenda, providing hundreds of oncology professionals from across the country and beyond with updates on clinical trials and opportunities to connect and collaborate. Continuing Medical …
At each Group Meeting, SWOG presents industry partners with the opportunity to exhibit their products and services over a two-day period. Benefits of participation include interaction with and exposure to hundreds of oncology professionals, high-profile placement of display areas, and inclusion of name and/or logo on meeting banners and in agenda booklets. In addition to its …
SWOG/Hope Foundation Impact Award (formerly The SWOG Development Award) The SWOG/Hope Foundation Impact Award is a funding program from The Hope Foundation that encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects. It is expected that support via this mechanism will lead to subsequent extramural support from other sources, …
Soham Puvvada, M.D., assistant professor of medicine at the University of Arizona, has been awarded a Charles A. Coltman, Jr., Fellowship from The Hope Foundation. The funding will support her development of a phase III randomized clinical trial that will compare rituximab-chemotherapy induction plus maintenance rituximab with or without ibrutinib in patients with newly diagnosed …
The Development Awards fund novel research with potential to inform future SWOG trials. The review committee most recently convened to conduct thorough evaluations of eleven applications. Two awards were granted: Dr. Omar Aljitawi “Pilot study exploring the use of hyperbaric oxygen in autologous PBSC transplantation” Dr. Robert Doebele “Evaluation of crizotinib resistance mechanisms to predict …
October 22-25, 2014. Hyatt Regency Chicago, Illinois Exhibits: October 23-24 The Hope Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
April 30-3, 2014. Hyatt Regency San Francisco, California. Exhibits: May 1-2 The Hope Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Michael LeBlanc, PhD
Group Statistician
JOIN OUR EMAIL LIST
We're honored to know you & collaborate with you, @LauraEsfeller - thank you for sharing your story and helping @SWOG improve care as an advocate!
With Gratitude for Trial Participants on #GivingTuesday
https://conta.cc/40WnDO8
Thank you, Anne Marie! 🥰
#GivingTuesday #SWOGonc
This is the final week to apply for 2023 @SWOG Early Exploration & Development #SEED Fund grants #SWOGonc
https://thehopefoundation.org/funding-opportunities/swog-early-exploration-development-seed-fund/
Thankful for our @SWOG cancer research community - at this time of year and always 💓
#SWOGonc
https://www.swog.org/news-events/news/2023/11/24/giving-thanks
The Hope Foundation provides funding to support travel for @SWOG Cancer Research Network member NCORP early stage investigators to attend the group’s annual meetings.
Apply by February 1 for the spring meeting! #SWOGonc
https://thehopefoundation.org/ncorp-esi-travel-funds/
Johanna Horn, President & CEO
;